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Abstract
Background: The risk of sporadic colorectal cancer (CRC) is mainly associated with lifestyle
factors, particularly dietary factors. Diets high in red meat and fat and low in fruit and vegetables
are associated with an increased risk of CRC. The dietary effects may be modulated by genetic
polymorphisms in biotransformation genes. In this study we aimed to evaluate the role of dietary
factors in combination with genetic factors in the different stages of colorectal carcinogenesis in a
Norwegian population.
Methods: We used a case-control study design (234 carcinomas, 229 high-risk adenomas, 762
low-risk adenomas and 400 controls) to test the association between dietary factors (meat versus
fruit, berries and vegetables) genetic polymorphisms in biotransformation genes (GSTM1, GSTT1,
GSTP1 Ile105Val, EPHX1 Tyr113His and EPHX1 His139Arg), and risk of colorectal carcinomas and
adenomas. Odds ratio (OR) and 95% confidence interval (95% CI) were estimated by binary logistic
regression.
Results: A higher ratio of total meat to total fruit, berry and vegetable intake was positively
associated with both high and low-risk adenomas, with approximately twice the higher risk in the
2nd quartile compared to the lowest quartile. For the high-risk adenomas this positive association
was more obvious for the common allele (Tyr allele) of the EPHX1 codon 113 polymorphism. An
association was also observed for the EPHX1 codon 113 polymorphism in the low-risk adenomas,
although not as obvious.
Conclusion: Although, the majority of the comparison groups are not significant, our results
suggest an increased risk of colorectal adenomas in individuals for some of the higher ratios of total
meat to total fruit, berry and vegetable intake. In addition the study supports the notion that the
biotransformation enzymes GSTM1, GSTP1 and EPHX1 may modify the effect of dietary factors on
the risk of developing colorectal carcinoma and adenoma.
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Background
Colorectal cancer (CRC) is one of the most prevalent dis-
eases in the industrialized Western countries. In Norway,
with one of the highest incidence rates in the world,
approximately 3500 new cases of CRC are diagnosed
every year [1].
Epidemiological studies have attributed more than 85%
of CRCs to environmental factors [2,3], particularly die-
tary factors [4]. Diets high in red meat and fat and low in
fruit and vegetables are associated with an increased risk
of CRC [5,6]. Although not entirely consistent, results
from case-control and cohort studies suggest a modest
association between intake of red meat and risk of CRC
[7-9]. The mechanism behind the specific risk-enhancing
effect of red meat is not precisely known, but there is evi-
dence suggesting that components of red meat may inde-
pendently increase the risk of CRC [10]. It has also been
suggested that any association between high meat con-
sumption and CRC may be a result of deficiencies in other
protective dietary factors, such as fruit and vegetables
[11,12]. In contrast to earlier studies, more recent epide-
miological studies have generally not supported a strong
influence of dietary fiber or fruit and vegetables, although
these have other health benefits [10]. This has led to the
notion that it is the ratio between meat and fruit/vegetable
intake that is important. A study by Kapiszewska [13]
showed that both the ratio between vegetables and meat
consumption, as well as the ratio between the amount of
energy from vegetables and animal products, can be used
successfully to evaluate the relation of dietary pattern to
cancer risk.
It is widely known that humans differ in their susceptibil-
ity to cancer. Difference in carcinogen metabolism might
explain the differences in cancer susceptibility especially
as most cancers are influenced by environmental factors
[14]. Dietary effects might be modulated by genetic poly-
morphisms in biotransformation genes [15]. In the
biotransformation system there are several interesting
genes including microsomal epoxide hydrolase (EPHX1)
(phase I) and gluthatione S-transferases (GSTs) (phase II),
all with known polymorphisms [16,17].
The EPHX1 gene has a dual function and catalyzes the
hydrolysis of arene, alkene and aliphatic epoxides to less
reactive and more water-soluble dihydrodiols, but acti-
vates some polycyclic aromatic hydrocarbons into a more
carcinogenic form [18]. A tyrosine to histidine substitu-
tion in exon 3 (Tyr113His) of the EPHX1 gene decreases in
vitro  enzyme activity by 40%, whereas a histidine to
arginine substitution in exon 4 (His139Arg) increases in
vitro enzyme activity by 25% [19].
GSTs are responsible for the glutathione conjugation and
detoxify a number of various reactive species [20]. Genetic
polymorphisms that result in reduced or absent activity or
expression of the GST enzyme are known for most GST
isoforms [21]. Research has mostly focused on the GSTM1
and GSTT1 deletion polymorphisms ("null" genotypes)
resulting in absence of the GST µ1 and GST µl enzymes
[22], and the GSTP1 Ile105Val polymorphism resulting in
a less active enzyme [23].
Several lines of evidence support the adenoma – carci-
noma sequence as the major path for colorectal carcino-
genesis. The present study aimed to investigate the role of
dietary factors (meat and fruit/vegetables) in combination
with genetic factors in the different stages of colorectal car-
cinogenesis in a Norwegian population.
Methods
The KAM cohort (Kolorektal cancer, Arv og Miljø) is based
on the screening group of the Norwegian Colorectal Can-
cer Prevention study (The NORCCAP study) in the county
of Telemark [24], and a series of clinical CRC cases (mean
age 67.3, SD 11.2) operated on at Telemark Hospital
(Skien) and Ulleval University Hospital (Oslo). Those
invited to participate in the NORCCAP study were 20,780
men and women, age 50–64 years old, drawn by rand-
omization from the population registry in Oslo (urban)
and the county of Telemark (mixed urban and rural). They
were invited to have a flexible sigmoidoscopy screening
examination with or without (1:1) an additional faecal
occult blood test (FOBT). Seven hundred and seventy-
seven individuals were excluded according to exclusion
criteria. The overall attendance rate was 65%. The ID
number for the NORCCAP study at ClinicalTrials.gov is I
NCT00119912 [25]. The screened cases in the NORCCAP
study selected for colonoscopy were invited to participate
in the KAM study (1044 cases agreed). During a limited
period of time, after the screening study of NORCCAP was
well established, controls (polyp free by flexible sig-
moidoscopy) were invited to participate in the KAM study
(400 controls agreed). The KAM cohort is based on an eth-
nic homogenous group of Norwegian origin. Written con-
sent was obtained from all the participants. The KAM
study is approved by the Regional Ethics Committee and
the Data Inspectorate.
The KAM biobank consists of blood and tissue samples
from 234 CRC cases (16 identified in the NORCCAP
screening group and 218 from hospitals), 1044 individu-
als identified with polyps in the large intestine (229 high-
risk and 762 low-risk adenomas, 53 hyperplastic polyps)
and 400 controls, defined as individuals with normal
findings at flexible sigmoidoscopy screening. Adenoma
cases and controls were all drawn from the NORCCAP
study. All of the participants completed a questionnaireBMC Cancer 2007, 7:228 http://www.biomedcentral.com/1471-2407/7/228
Page 3 of 11
(page number not for citation purposes)
on demographics, health status, dietary and smoking hab-
its, alcohol consumption, physical exercise and occupa-
tion. The questionnaire contained information on a
family history of adenomas and carcinomas, and the cases
and controls included had no known personal history of
genetic predisposition.
Diet was assessed in cases and controls using an extensive
diet and lifestyle questionnaire, modeled on a question-
naire developed and validated for an American breast can-
cer study [26-28]. It was designed in a food frequency
manner, asking the participants to record their average
consumption, during the last year, of a wide range of typ-
ically Norwegian food items by ticking off fixed frequency
and portion size boxes. Nine frequency choices, ranging
from "never/less than once per month" to "2 or more per
day" were given, whereas portion size was recorded as
small, medium or large. The medium portion size was
defined in the questionnaire (e.g. units, grams, dl). A
small portion was defined as half or less than half of the
medium portion, and a large portion was defined as one
and a half or more of the medium portion. All question-
naires were checked for mistakes and completeness, and
the participants who had delivered an inadequate ques-
tionnaire were contacted by phone in order to improve
the quality of the data.
The adenocarcinomas were collected prior to chemo- or
radiotherapy treatment. Two specialists in histopathology
examined the histology of the adenomas independently
in order to determine the tumor stage as mild, moderate
or severe dysplasia. They reached the same conclusion in
all cases.
Diminished numbers of available cases in the KAM
biobank and analyzed cases are due to loss of samples
during preparation and/or lack of information from the
questionnaires. The 53 hyperplastic polyps were not
included in the present analysis. A high-risk adenoma was
defined as an adenoma measuring = 10 mm in diameter
and/or with villous components and/or showing severe
dysplasia [24].
Genomic DNA was isolated from blood samples accord-
ing to standard procedures [29] with minor modifications
as previously described [30].
Polymorphisms of the GSTM1 (null), GSTT1 (null) and
GSTP1 (Ile105Val) genes were analyzed simultaneously by
multiplex PCR as described by Nedelcheva Kristensen et
al.[31].
The  EPHX1  His139Arg polymorphism (rs2234922) was
analyzed by a PCR-RFLP (restriction fragment length pol-
ymorphism) method as described by Hasset et al.[19].
Genotype analysis of the EPHX1 Tyr113His polymorphism
(rs1051740) was carried out using the TaqMan allelic dis-
crimination assay on a Sequence Detection System ABI
7000 (Applied Biosystems), using the primers forward: 5'-
TCT CCT ACT GGC GGA ATG AAT T-3', reverse: 5'-CTG
GCT GGC GTT TTG CA-3' and the probes T-allele: 5'-VIC-
TCT CAA CAG ATA CCC TCA-MGB-3', C-allele: 5'-6-FAM-
TCA ACA GAC ACC CTC A-MGB-3'. The polymorphism
was determined in a 12 µl reaction containing 1× Master-
Mix, 200 nM of each probe, 900 nM primers, and ca 50 ng
of genomic DNA. Cycling conditions were as follows:
50°C for 2 min, 95°C for 10 min, and 45 cycles of 95°C
for 15 s and 60°C for 1 min. Controls were included in
each run, and 10% of the samples were retyped with iden-
tical results.
Eight summary variables were created from the individual
dietary items in the food frequency questionnaire to
describe the intake of red meat, processed meat, total
meat, raw vegetables, boiled vegetables, fruit and berries,
total fruit, berries and vegetables and the ratio between
total meat and fruit, berry and vegetable intake. For each
individual dietary factor, the frequency and portion size
were multiplied to obtain the amount in grams per day.
The summary variables were then divided into quartiles
based on distribution of consumption among controls.
Differences in characteristics between the control group
and all the case groups were assessed using the χ2 test for
categorical variables and the Mann-Whitney test for con-
tinuous variables. P-values < 0.05 were considered signif-
icant. Odds ratios (ORs) and 95% confidence intervals
(CI) were calculated using binary logistic regression anal-
ysis to assess the relationship between the dietary factors,
each polymorphism and colorectal carcinoma or ade-
noma cases. Crude ORs were calculated, adjusted for age
and gender only. In addition multiple logistic regression
analyses were performed with an adjustment for age, gen-
der, smoking dose, alcohol consumption, and when
appropriate total meat consumption and total fruit, berry
and vegetable consumption. In addition the modifying
effect by genotype on dietary exposure (ratio of total meat
to total fruit, berry and vegetable intake) was studied by
stratification in a two by four table. All analyses were car-
ried out using the statistical analysis software SPSS (Chi-
cago, Illinois, USA) 12.0.1 for Windows.
Results
Selected characteristics of cases and controls are shown in
Table 1. The gender distribution was dissimilar in the con-
trol and the case groups. Cases were older and more often
smokers. The low-risk adenoma cases had a higher alco-
hol intake than the controls. Low-risk adenoma cases had
a higher total meat intake than controls, and the high andBMC Cancer 2007, 7:228 http://www.biomedcentral.com/1471-2407/7/228
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low-risk adenoma cases had a higher ratio of intake of
total meat to total fruit, berries and vegetables.
The distribution of consumption of the dietary factors in
quartiles is presented in Table 2, and the genotype distri-
bution is shown in Table 3. The tables also present the
estimates of ORs of colorectal carcinomas and adenomas
associated with the various dietary factors and polymor-
phisms. The tables present only data from the multi-
adjusted model which may be a better choice than the
crude model in reducing potential confounding in the
data.
No significant trends were observed in the data of Table 2.
Total meat consumption showed a borderline significant
association with low-risk adenomas in the 3rd quartile, OR
of 1.57 (95% CI 1.00–2.46). No significant results were
observed for total fruit, berry and vegetable consumption.
The ratio of total meat to total fruit, berry and vegetable
intake was positively associated with both high and low-
risk adenomas in the 2nd quartile (and 3rd quartile for low-
risk adenomas) with approximately twice the higher risk
compared to the lowest quartile (ORs of 2.59 (95% CI
1.31–5.14) and 1.73 (95% CI 1.08–2.75), respectively).
We have also tested the dietary exposures as binary varia-
bles, but these results gave less information than the cho-
sen model (data not shown).
The frequencies for the GSTM1 null allele, GSTT1 null
allele,  GSTP1  105Val allele, EPHX1  113His allele and
EPHX1  139Arg allele among the controls were respec-
tively, 0.52, 0.13, 0.37, 0.32 and 0.21 (Table 3). The gen-
Table 1: Distribution of age, gender, cigarette smoking, alcohol consumption and dietary factors among controls and cases with 
colorectal carcinomas and adenomas
Controls Carcinomas High-risk adenomas Low-risk adenomas
No. of subjects 400 234 229 762
Gendera
Male, No (%) 157 (39.3) 128 (54.7) 151 (65.9) 456 (59.8)
Female, No (%) 243 (60.8) 106 (45.3) 78 (34.1) 306 (40.2)
Ageb
Mean, years (SD) 54.2 (3.3) 67.3(11.2) 57.3 (3.5) 57.3 (3.8)
Smoking status
Never smoked, No (%) 156 (46.7) 67 (38.5) 52 (27.1) 206 (31.5)
Ever smoked, No (%) 178 (53.3) 107 (61.5) 140 (72.9) 448 (68.5)
Number of cigarette yearsc, median (25–75 percentile) 213 (58.8–362.0) 300 (120.0–546.0) 350 (210.3–484.8) 314 (137.0–468.0)
Alcohol consumption
Never, No (%) 73 (21.8) 43 (25.3) 45 (22.6) 147 (21.9)
Ever, No (%) 262 (78.2) 127 (74.7) 154 (77.4) 523 (78.1)
Number of alcohol units per monthd, median (25–75 percentile) 6.5 (2.5–16.0) 10.5 (4.0–25.0) 9.0 (5.0–20.1) 9.0 (4.5–19.0)
Dietary intake in g/day, median (25–75 percentile)
Red meat consumption 25 (16.5–45.0) 24 (12.0–39.4) 27 (16.5–45.0) 27 (16.5–45.0)
Processed meat consumptione 70 (40.2–112.9) 62 (31.6–95.2) 77 (42.1–120.9) 77 (46.1–113.6)
Total meat consumptionf 99 (63.5–154.5) 90 (53.4–134.5) 112 (71.0–163.0) 112 (74.9–154.9)
Raw vegetable consumption 52 (22.8–84.8) 41 (19.2–81.0) 42 (19.9–75.0) 45 (22.9–80.1)
Boiled vegetable consumptiong 58 (34.9–94.7) 74 (39.2–108.1) 64 (38.7–100.3) 67 (40.2–108.3)
Fruit and berry consumptionh 141 (74.1–224.3) 106 (51.9–190.1) 122 (54.7–200.5) 118 (59.7–199.6)
Total fruit, berry and vegetable consumption 265 (166.4–390.9) 250 (149.7–378.4) 230 (156.2–372.1) 241 (157.6–358.7)
Ratio of total meat to total fruit, berry and vegetable intakei 0.38 (0.19–0.71) 0.40 (0.20–0.63) 0.43 (0.26–0.76) 0.45 (0.27–0.82)
a There are significant differences in the number of males and females between the control group and all the case groups, P < 10-4.
b There are significant differences in age between the control group and all the case groups, P < 10-4.
c There are significant differences in number of cigarette years (smoking dose) between the control group and all of the case groups, P = 0.001, P < 
10-4 and P < 10-4, respectively.
d There is significant difference in number of alcohol units per month between the control group and the low-risk adenoma group, P = 0.013.
e There is significant difference in processed meat consumption (g/day) between the control group and the low-risk adenoma group, P = 0.041.
f There is significant difference in total meat consumption (g/day) between the control group and the low-risk adenoma group, P = 0.027.
g There is significant difference in boiled vegetable consumption (g/day) between the control group and the low-risk adenoma group, P = 0.035.
h There are significant differences in fruit and berry consumption (g/day) between the control group and the carcinoma and low-risk adenoma 
groups, P = 0.019 and P = 0.005, respectively.
i There are significant differences in ratio of total meat to total fruit, berry and vegetable intake between the control group and the high- and low-
risk adenoma groups, P = 0.035 and P = 0.003, respectively.
Missing values for cigarette smoking, alcohol consumption and dietary factors gave rise to diminished number of cases and controls.BMC Cancer 2007, 7:228 http://www.biomedcentral.com/1471-2407/7/228
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Table 2: Association between intake of dietary factors and colorectal carcinomas and adenomas
Controls Carcinomas OR (95% CI)a High-risk adenomas OR (95% CI)a Low-risk adenomas OR (95% CI)a
Dietary factorsb
Total meat
≤ 64 72 37 1 (ref) 35 1 (ref) 107 1 (ref)
> 64 and ≤ 99 77 29 1.00 (0.43–2.32) 42 1.07 (0.56–2.06) 139 1.05 (0.66–1.67)
> 99 and ≤ 155 77 33 1.88 (0.82–4.31) 49 1.46 (0.76–2.78) 186 1.57 (1.00–2.46)
> 155 74 27 0.93 (0.38–2.30) 49 1.22 (0.63–2.37) 149 1.06 (0.66–1.70)
Ptrend = 0.67 Ptrend = 0.41 Ptrend = 0.43
Total fruit, berry and vegetable
≤ 166 76 36 1 (ref) 53 1 (ref) 159 1 (ref)
> 166 and ≤ 265 73 35 0.82 (0.36–1.88) 49 1.00 (0.55–1.80) 168 1.12 (0.73–1.74)
> 265 and ≤ 391 75 27 0.83 (0.36–1.92) 37 0.78 (0.41–1.46) 130 1.02 (0.65–1.59)
> 391 75 28 1.52 (0.67–3.45) 36 1.03 (0.55–1.95) 124 0.99 (0.63–1.57)
Ptrend = 0.37 Ptrend = 0.86 Ptrend = 0.87
Ratio of total meat to total fruit, berry and vegetable intake
≤ 0.19 75 27 1 (ref) 22 1 (ref) 90 1 (ref)
> 0.19 and ≤ 0.38 74 33 1.66 (0.72–3.84) 55 2.59 (1.31–5.14) 146 1.73 (1.08–2.75)
> 0.38 and ≤ 0.71 75 45 1.58 (0.69–3.63) 45 1.49 (0.73–3.02) 176 1.68 (1.06–2.67)
> 0.71 75 21 0.62 (0.23–1.62) 53 1.92 (0.95–3.91) 169 1.39 (0.85–2.25)
Ptrend = 0.39 Ptrend = 0.37 Ptrend = 0.29
a Adjusted for age, gender, smoking dose and alcohol consumption. In addition 'Total meat' and 'Total fruit, berry and vegetable' are mutually 
adjusted for when assessing their main effect. These variables were not adjusted for when the ratio between them was assessed.
b Quantities are gram per day. Categories based on quartiles. Numbers vary between the dietary factors due to missing dietary data.
ref: served as reference category.
Table 3: Association between GST and EPHX1 genotypes and colorectal carcinomas and adenomas
Controls Carcinomas OR (95% CI)a High-risk adenomas OR (95% CI)a Low-risk adenomas OR (95% CI)a
Genotypesb
GSTM1
Present 148 53 1 (ref) 84 1 (ref) 262 1 (ref)
Null 151 55 1.22 (0.65–2.30) 89 0.98 (0.63–1.52) 313 1.09 (0.80–1.49)
GSTT1
Present 262 93 1 (ref) 143 1 (ref) 488 1 (ref)
Null 37 15 1.37 (0.57–3.31) 30 1.36 (0.72–2.55) 87 0.99 (0.63–1.58)
GSTP1 Ile105Val
Ile/Ile 119 51 1 (ref) 57 1 (ref) 240 1 (ref)
Ile/Val 140 50 0.82 (0.43–1.59) 90 1.27 (0.78–2.06) 272 1.00 (0.71–1.39)
Val/Val 40 7 0.38 (0.12–1.23) 26 1.29 (0.65–2.59) 63 0.79 (0.48–1.32)
Ile/Val + Val/Val 180 57 0.71 (0.38–1.32) 116 1.27 (0.80–2.02) 335 0.95 (0.69–1.31)
Ptrend = 0.13 Ptrend = 0.35 Ptrend = 0.49
EPHX1 Tyr113His
Tyr/Tyr 132 52 1 (ref) 75 1 (ref) 304 1 (ref)
Tyr/His 134 41 0.74 (0.37–1.47) 81 0.90 (0.57–1.44) 229 0.69 (0.50–0.97)
His/His 33 9 1.04 (0.33–3.21) 17 0.87 (0.40–1.88) 43 0.56 (0.32–0.99)
Tyr/His + His/His 167 50 0.78 (0.41–1.51) 98 0.90 (0.57–1.40) 272 0.67 (0.49–0.92)
Ptrend = 0.68 Ptrend = 0.63 Ptrend = 0.01
EPHX1 His139Arg
His/His 190 56 1 (ref) 106 1 (ref) 347 1 (ref)
His/Arg 90 27 1.24 (0.60–2.57) 59 1.37 (0.85–2.21) 207 1.24 (0.88–1.74)
Arg/Arg 19 18 2.70 (0.96–7.58) 8 0.62 (0.23–1.70) 22 0.51 (0.25–1.06)
His/Arg + Arg/Arg 109 45 1.52 (0.79–2.93) 67 1.22 (0.77–1.91) 229 1.11 (0.80–1.53)
Ptrend = 0.09 Ptrend = 0.82 Ptrend = 0.83
a Adjusted for age, gender, smoking dose, alcohol consumption, and the consumption of total meat and total fruit, berry and vegetable.
b Numbers vary between analyzed genotypes due to missing samples and/or failed analysis.
ref: the genotype served as reference category.BMC Cancer 2007, 7:228 http://www.biomedcentral.com/1471-2407/7/228
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otype distributions were all in Hardy-Weinberg
equilibrium and the distributions of the alleles are in
agreement with those found in other Caucasian popula-
tions [32-34]. No significant associations were found
between the GST polymorphisms and risk of colorectal
carcinomas and adenomas. The EPHX1 113His allele was
associated with a decreased risk in low-risk adenomas
with OR of 0.67 (95% CI 0.49–0.92), Ptrend = 0.01. No sig-
nificant associations were seen between the EPHX1
139Arg allele and carcinomas and adenomas. Since the
strongest association seems to be with the Arg/Arg geno-
type we have compared this genotype with the combined
His/His and His/Arg genotypes as a reference. The Arg/Arg
genotype was associated with decreased risk of low-risk
adenomas only, OR of 0.48 (95% CI 0.23–0.98) (data not
shown). We have also tested the combined effect of the
two polymorphisms in EPHX1  (i.e., Tyr113His and
His139Arg). Predicted mEPHX activities were classified as
normal, fast and slow [35]. The same tendency was
observed as for the separate genotypes (data not shown).
Table 4 display the results from analyses of the effect of
the ratio of total meat to total fruit, berry and vegetable
intake on the risk of colorectal carcinomas and adenomas
stratified by genotype. The case groups are stratified based
on polymorphic status, in most common allele or any
polymorphic allele. Only data from the multi-adjusted
model is presented.
No significant trends were observed. For carcinomas we
did not find any significant association with ratio of total
meat to total fruit, berry and vegetable intake, and the
combination with genotype gives few significant results. A
reduced risk (Q4) was observed in individuals with the
GSTP1 codon 105 variant allele (Val allele). In addition a
positive association between ratio (Q2) and CRC risk was
more obvious in individuals with the EPHX1 codon 139
common allele (His allele).
A higher ratio of total meat to total fruit, berry and vegeta-
ble intake was positively associated with colorectal adeno-
mas. For the high-risk adenomas this positive association
was more obvious for the common allele (Tyr allele) of
the EPHX1 codon 113 polymorphism. The same was seen
for the EPHX1 codon 113 polymorphism in the low-risk
adenomas, although not so obvious. The ratio (Q2) was
also associated with an increased risk of high-risk and
low-risk adenomas in individuals with the GSTM1 com-
mon allele and the GSTP1 codon 105 variant allele (Val
allele).
Statistical analysis of the modifying effect by the GSTT1
polymorphism on the ratio of total meat to total fruit, ber-
ries and vegetables intake was not possible to perform due
to low sample size.
Discussion
Sporadic CRC is a consequence of multiple risk factors,
among which the interaction between environmental and
genetic factors is of particular interest. In this case-control
study we investigated whether the consumption of meat
and fruit, berries and vegetables or selected genotypes was
associated with risk of developing colorectal carcinomas
and adenomas alone or if the genotypes could modify the
results.
We found only a weak positive association between total
meat consumption and low-risk adenomas. Lack of signif-
icant association with the cancer group and the high-risk
adenoma group, may be due to small sample size. There
appears to be consistent evidence from epidemiological
data that intake of red meat is positively related to risk of
developing CRC [8,9]. Enhanced risk of colorectal adeno-
mas, an established precursor lesion of CRC, has also
been associated with high levels of red meat consumption
in some studies [36,37] but not in others [38,39].
We did not detect any association between fruit, berry and
vegetable intake and risk of developing colorectal carcino-
mas or adenomas. The association between fruit and veg-
etables consumption has not been consistently proven in
other studies. The majority of case-control studies show
an inverse association between intake of vegetables and
colon cancer risk, while prospective studies show no asso-
ciation [40]. Distribution of meat, vegetable, fruit and
berry consumption in our study is in agreement with the
NORKOST survey, a nation-wide survey of a representa-
tive sample of the adult population in Norway [41].
The ratio between total meat and total fruit, berry and veg-
etable intake yielded an increased risk of high and low-
risk adenomas for the 2nd quartile (and also the 3rd quar-
tile for low-risk adenomas) compared to the lower quar-
tile. This result may apply to the general Norwegian
population which has little variation in intake of meat,
fruit, berries and vegetables. The result is in agreement
with the result of Turner et al.[42] who showed that sub-
jects who consumed small amounts of fruit and vegeta-
bles per month and many servings of red meat were at
greater risk of CRC. The results also support the hypothe-
sis of Kapiszewska [13] who has argued that it is not the
consumption of a single food product or an individual
component of diet, but rather a proper ratio of vegetables
to meat consumption that contributes to cancer preven-
tion. Lack of balance between the amount of meat and
fruit, berries and vegetables may lead to the accumulation
of damaged DNA, initiating DNA instability and inducing
cancer development.
The GSTM1, GSTT1 and GSTP1 polymorphisms were not
associated with risk of colorectal carcinomas and adeno-B
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Table 4: Ratios of total meat to total fruit, berry and vegetable intake and the risk of colorectal carcinomas and adenomas by GST and EPHX1 genotypes
OR (95% CI)a (Ncases/Ncontrols)
Case group Ratio of total meat to total 
fruit, berry and vegetable 
intakeb
GSTM1 GSTP1 Ile105Val EPHX1 Tyr113His EPHX1 His139Arg
Present Null Ile/Ile Ile/Val+Val/Val Tyr/Tyr Tyr/His+His/His His/His His/Arg+Arg/Arg
Carcinomas Q1 1 (ref) (11/39) 1 (ref) (11/36) 1 (ref) (7/32) 1 (ref) (15/43) 1 (ref) (10/33) 1 (ref) (10/42) 1 (ref) (9/51) 1 (ref) (11/24)
Q2 0.84 (0.20–3.47) 
(11/33)
2.99 (0.85–10.5) 
(18/40)
2.01 (0.53–7.67) 
(16/27)
1.52 (0.43–5.35) 
(13/46)
3.28 (0.63–17.0) 
(17/29)
1.65 (0.51–5.41) 
(12/44)
4.67 (1.21–18.0) 
(17/48)
0.69 (0.17–2.89) 
(12/25)
Q3 1.05 (0.31–3.57) 
(19/43)
2.39 (0.63–9.02) 
(18/32)
1.85 (0.48–7.18) 
(15/31)
1.22 (0.36–4.13) 
(22/44)
2.59 (0.47–14.3) 
(18/36)
1.34 (0.40–4.42) 
(17/39)
2.78 (0.71–11.0) 
(20/45)
0.63 (0.16–2.55) 
(14/30)
Q4 0.49 (0.10–2.41) 
(12/33)
0.78 (0.19–3.23) (8/
42)
1.61 (0.41–6.40) 
(13/28)
0.11 (0.01–0.88) (7/
47)
0.70 (0.11–4.59) (7/
33)
0.63 (0.16–2.52) 
(11/42)
0.90 (0.20–4.13) 
(10/46)
0.34 (0.07–1.72) (8/
29)
Ptrend = 0.55 Ptrend = 0.51 Ptrend = 0.58 Ptrend = 0.10 Ptrend = 0.56 Ptrend = 0.51 Ptrend = 0.74 Ptrend = 0.21
High-risk 
Adenomas
Q1 1 (ref) (11/39) 1 (ref) (11/36) 1 (ref) (9/32) 1 (ref) (13/43) 1 (ref) (5/33) 1 (ref) (17/42) 1 (ref) (15/51) 1 (ref) (7/24)
Q2 3.52 (1.26–9.85) 
(32/33)
2.05 (0.80–5.26) 
(23/40)
2.54 (0.85–7.54) 
(20/27)
2.67 (1.09–6.51) 
(35/46)
8.98 (2.54–31.8) 
(33/29)
1.26 (0.52–3.05) 
(22/44)
2.55 (1.05–6.24) 
(29/48)
2.68 (0.88–8.19) 
(26/25)
Q3 1.49 (0.53–4.21) 
(22/43)
1.57 (0.59–4.20) 
(23/32)
1.32 (0.42–4.16) 
(12/31)
1.42 (0.57–3.56) 
(33/44)
3.38 (0.90–12.75) 
(16/36)
1.08(0.45–2.63) (29/
39)
2.00 (0.81–4.94) 
(31/45)
0.93 (0.28–3.10) 
(14/30)
Q4 1.83 (0.59–5.63) 
(19/33)
1.91 (0.74–4.92) 
(32/42)
1.89 (0.60–5.95) 
(16/28)
1.68 (0.67–4.19) 
(35/47)
3.65 (1.00–13.3) 
(21/33)
1.44 (0.59–3.52) 
(30/42)
1.94 (0.77–4.88) 
(31/46)
1.65 (0.52–5.26) 
(20/29)
Ptrend = 0.81 Ptrend = 0.34 Ptrend = 0.59 Ptrend = 0.74 Ptrend = 0.67 Ptrend = 0.51 Ptrend = 0.33 Ptrend = 0.94
Low-risk 
adenomas
Q1 1 (ref) (36/39) 1 (ref) (54/36) 1 (ref) (44/32) 1 (ref) (46/43) 1 (ref) (38/33) 1 (ref) (52/42) 1 (ref) (57/51) 1 (ref) (33/24)
Q2 2.62 (1.28–5.35) 
(65/33)
1.32 (0.70–2.48) 
(77/40)
1.38 (0.67–2.83) 
(52/27)
2.02 (1.08–3.77) 
(90/46)
2.65 (1.28–5.46) 
(83/29)
1.15 (0.61–2.14) 
(59/44)
1.67 (0.94–2.98) 
(82/48)
1.86 (0.83–4.15) 
(60/25)
Q3 1.89 (0.96–3.74) 
(81/43)
1.63 (0.85–3.12) 
(94/32)
1.42 (0.71–2.85) 
(70/31)
1.86 (1.00–3.47) 
(105/44)
2.07 (1.02–4.20) 
(93/36)
1.36 (0.73–2.54) 
(82/39)
1.64 (0.91–2.93) 
(97/45)
1.70 (0.78–3.71) 
(78/30)
Q4 1.89 (0.90–3.98) 
(80/33)
1.06 (0.55–2.04) 
(88/42)
1.25 (0.60–2.65) 
(74/28)
1.43 (0.75–2.73) 
(94/47)
1.57 (0.74–3.35) 
(90/33)
1.23 (0.65–2.33) 
(79/42)
1.52 (0.83–2.79) 
(111/46)
1.13 (0.50–2.56) 
(58/29)
Ptrend = 0.25 Ptrend = 0.80 Ptrend = 0.55 Ptrend = 0.48 Ptrend = 0.49 Ptrend = 0.46 Ptrend = 0.22 Ptrend = 0.98
a OR adjusted for age, gender, smoking dose and alcohol consumption.
b Quartiles of ratio of total meat to total fruit, berry and vegetable intake, per day: ≤ 0.19, >0.19 and ≤ 0.38, > 0.38 and ≤ 0.71, > 0.71.
ref: The combination served as a reference.BMC Cancer 2007, 7:228 http://www.biomedcentral.com/1471-2407/7/228
Page 8 of 11
(page number not for citation purposes)
mas in this study. This is consistent with the results in
some studies [33,43], but only partly in others [44].
The EPHX1 113His allele was associated with a decreased
risk of low-risk adenomas. The EPHX1 codon 139 poly-
morphism was not associated with risk of carcinomas and
adenomas in this study. Contradictory data have been
provided by different studies investigating the EPHX1
codon 113 and EPHX1 codon 139 polymorphisms in rela-
tion to the risk of colorectal carcinomas and adenomas
[45-50].
There is conflicting evidence regarding the role of GST and
EPHX1 polymorphisms in CRC susceptibility. Since the
enzymes have detoxifying activity, it would be expected
that, rather than affecting the risk of cancer per se, they
would modify risk when exposed to potential carcinogens
[22].
To evaluate if the genetic polymorphisms in GST  and
EPHX1 modify colorectal carcinoma and adenoma risk in
relation to ratio of total meat to total fruit, berry and veg-
etable intake, we stratified the case groups based on the
most common allele or any polymorphic allele.
The most convincing evidence of a modifying effect by
genotype on dietary exposure was found between EPHX1
codon 113 in adenomas and EPHX1 codon 139 in carci-
nomas. In our study, for both the EPHX1 codon 113 and
EPHX1  codon 139 polymorphisms, the increased risk
associated with a higher ratio of total meat to total fruit,
berries and vegetables was confined to individuals
homozygous for the most common alleles (EPHX1
113Tyr allele and EPHX1 139His allele). To our knowl-
edge no studies have been published on the association
between GST and EPHX1 polymorphisms and the ratio of
total meat to total fruit, berry and vegetable intake, but
some studies have looked at the gene-diet interaction with
meat and fruit/vegetables separately. There are few reports
on the association between EPHX1 polymorphisms and
dietary factors. Cortessis et al.[46] reported increased risk
of adenomas in individuals who ate their meat well done
and had a high predicted EPHX1 activity (combination
with 3 or 4 of the more stable alleles, defined as the Y
(tyrosine) variant at exon 3 and the R (arginine) variant at
exon 4), whereas Ulrich et al.[51] reported elevated ade-
noma risks associated with low predicted activity in those
with high intake of cooked meat. Other reports on EPHX1
and CRC and adenomas did not find evidence for an
interaction with meat intake [42,47,48,50]. One report
has suggested a weak interaction between fruit consump-
tion and the EPHX1 113Tyr allele (common allele) [42],
but due to unusual allele frequencies and unexpected pat-
tern of results (greatest risk reduction in the intermediate
genotype group) this finding must be interpreted with
caution. The biochemical pathways in which EPHX1 par-
ticipates involve numerous enzymes. The role of EPHX1
itself maybe quite complex, as the enzyme has broad sub-
strate specificity and tissue distribution. Expression of
EPHX1 is both induced and inhibited by exogenous com-
pounds [52]. While EPHX1 usually results in detoxifica-
tion of xenobiotic substances, it is also involved in the
metabolic activation of polycyclic aromatic hydrocarbons
found in cooked meat, triggering the formation of highly
reactive metabolites that can damage DNA, RNA and pro-
tein components [35,53]. EPHX1 activity may also be
modulated by components in fruit and vegetables. It is
likely that EPHX1 could modify the association between
diet and colorectal carcinoma and adenoma risk.
In addition we found weak evidence of a modifying effect
by the GSTP1 and GSTM1 genotypes on the ratio of total
meat to total fruit, berry and vegetable intake in adeno-
mas. The increased risk associated with a higher ratio of
total meat to total fruit, berries and vegetables is restricted
to individuals with the GSTP1 codon 105 variant allele
(Val allele), and to the GSTM1 common allele. Since there
are no significant trends and only a few significant single
results caution is required in interpretation of our find-
ings.
Studies have shown that higher levels of DNA damage are
associated with the GSTM1/T1  null genotypes and the
GSTP1 105Val allele [54,55]. The higher adenoma risk
with a low capacity GST variant could directly reflect the
slower processing of genotoxic compounds associated
with meat intake. In addition a high ratio of meat to fruit,
berries and vegetables may increase the risk of carcinogen-
esis.
Isothiocyanates (component of fruit and vegetables) are
substrates for GSTs [56-58] and thus GSTs contribute to
the excretion of isothiocyanates. The involvement of GSTs
in isothiocyanate metabolism has led to the hypothesis
that, through slower excretion of isothiocyanates from the
body in individuals with genetic variants associated with
lower GST capacity, isothiocyanates have greater opportu-
nity to exert their chemo-protective effects in these indi-
viduals [59].
As with any case-control study, there is a possibility of bias
in recall of diet leading to spurious associations. But for
the assessment of gene-environment interactions this is
not an issue, since there is no corresponding risk of bias in
relation to genotype. We cannot exclude the possibility
that the associations may be confounded or modified by
other genetic or dietary factors. The CRC cases and con-
trols have not been matched by age, which may affect the
results in our study. However, the controls were recruited
from the same population as the adenoma and carcinomaBMC Cancer 2007, 7:228 http://www.biomedcentral.com/1471-2407/7/228
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cases. Further, our controls have been screened and found
polyp free by flexible sigmoidoscopy and the risk of any
of them having colon cancer at the time of inclusion is not
very likely. It has been estimated that less than 3% of indi-
viduals with no adenoma at flexible sigmoidoscopy are
likely to harbor an undiagnosed proximal advanced color-
ectal neoplasia [60].
Due to the high number of multiple tests and compari-
sons in the present study, some statistically significant
associations have undoubtedly occurred by chance, and
caution is required in their interpretation. The results thus
need to be verified by further studies with particular focus
on the ratio between meat and fruit, berry and vegetable
intake and the possible modifying effects of biotransfor-
mation genes.
Conclusion
Although, the majority of the comparison groups are not
significant, our results suggest an increased risk of colorec-
tal adenomas in individuals for some of the higher ratio
of total meat to total fruit, berry and vegetable intake. An
unbalanced consumption of meat and fruit, berries and
vegetables may lead to accumulation of DNA damage and
thus increased risk of cancer development. In addition the
study supports the notion that the biotransformation
enzymes GSTM1, GSTP1 and EPHX1 may modify the
effect of dietary factors on the risk of developing colorectal
carcinoma and adenoma.
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